These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17515471)

  • 1. Letter by Ridker and Everett regarding article, "The inflammatory hypothesis: any progress in risk stratification and therapeutic targets?".
    Ridker PM; Everett BM
    Circulation; 2007 May; 115(20):e475; author reply e476. PubMed ID: 17515471
    [No Abstract]   [Full Text] [Related]  

  • 2. The inflammatory hypothesis: any progress in risk stratification and therapeutic targets?
    Blankenberg S; Yusuf S
    Circulation; 2006 Oct; 114(15):1557-60. PubMed ID: 17030701
    [No Abstract]   [Full Text] [Related]  

  • 3. [Inflammation and C-reactive protein in cardiovascular disease].
    Munk PS; Larsen AI
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRP has little incremental value over traditional cardiovascular risk factors in risk stratification.
    Farkouh ME; Bansilal S; Mathew V
    Nat Clin Pract Cardiovasc Med; 2007 Jun; 4(6):290-1. PubMed ID: 17522718
    [No Abstract]   [Full Text] [Related]  

  • 5. [A commentary to the article by Dvoráková, Poledne: "An ultrasensitive C-reactive protein assay--a new parameter of a cardiovascular risk" sent from the Laboratory for Aterosclerosis Investigation at IKEM Prague].
    Málek F
    Vnitr Lek; 2004 Nov; 50(11):807-9. PubMed ID: 15648957
    [No Abstract]   [Full Text] [Related]  

  • 6. A better way to predict cardiovascular risk. We know how important cholesterol levels are, but what about inflammation?
    Harv Womens Health Watch; 2007 Apr; 14(8):1-2. PubMed ID: 17441261
    [No Abstract]   [Full Text] [Related]  

  • 7. C-reactive protein in the prediction of cardiovascular events.
    Brezis M
    N Engl J Med; 2003 Mar; 348(11):1059-61; author reply 1059-61. PubMed ID: 12638579
    [No Abstract]   [Full Text] [Related]  

  • 8. [C-reactive protein--a molecule that changed cardiology].
    Ostádal P
    Vnitr Lek; 2004 Nov; 50(11):809-11. PubMed ID: 15648958
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter by Timpson et al regarding article, "Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level".
    Timpson NJ; Smith GD; Ebrahim S
    Circulation; 2006 Aug; 114(7):e256. PubMed ID: 16908780
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple biomarkers and cardiovascular risk.
    Austin MJ; Heneghan MA
    N Engl J Med; 2008 Aug; 359(7):760-1; author reply 761. PubMed ID: 18711791
    [No Abstract]   [Full Text] [Related]  

  • 11. C-reactive protein and heart attack risk.
    Harv Womens Health Watch; 2000 May; 7(9):7. PubMed ID: 10762537
    [No Abstract]   [Full Text] [Related]  

  • 12. The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.
    Kones R
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):309-15. PubMed ID: 19460829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of C-reactive protein for cardiovascular risk stratification across three age groups in subjects without existing cardiovascular diseases.
    Hamer M; Chida Y; Stamatakis E
    Am J Cardiol; 2009 Aug; 104(4):538-42. PubMed ID: 19660608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-sensitivity C-reactive protein for risk stratification in patients with heart failure.
    Bauters C; Lamblin N; de Groote P
    Am Heart J; 2008 Feb; 155(2):e7; author reply e9. PubMed ID: 18215583
    [No Abstract]   [Full Text] [Related]  

  • 15. Predicting benefit from statins by C-reactive protein, LDL-cholesterol or absolute cardiovascular risk.
    Stewart RA
    Future Cardiol; 2009 May; 5(3):231-6. PubMed ID: 19656039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiovascular risk factors--where do these come from? Interview by Nicola von Lutterotti].
    Assmann G
    Dtsch Med Wochenschr; 2005 Oct; Suppl 1():33-4. PubMed ID: 16379234
    [No Abstract]   [Full Text] [Related]  

  • 17. C-reactive protein predicts future arterial and cardiovascular events in patients with symptomatic peripheral arterial disease.
    Hogh AL; Joensen J; Lindholt JS; Jacobsen MR; Ostergaard L
    Vasc Endovascular Surg; 2008; 42(4):341-7. PubMed ID: 18458051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of plasma pro-inflammatory cytokines, fibrinogen, viscosity and C-reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study.
    Welsh P; Woodward M; Rumley A; Lowe G
    Br J Haematol; 2008 Jun; 141(6):852-61. PubMed ID: 18371109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of biomarkers for risk stratification in the prevention of cardiovascular diseases].
    Sinning C; Keller T; Blankenberg S
    Dtsch Med Wochenschr; 2009 Oct; 134(40):2019-22. PubMed ID: 19777420
    [No Abstract]   [Full Text] [Related]  

  • 20. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus.
    Ridker PM
    J Am Coll Cardiol; 2007 May; 49(21):2129-38. PubMed ID: 17531663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.